Eden Biosolutions PLC (EDEN.L) LSE

Currency In GBp

AD

Valuation

Market Cap15.14M
Enterprise Value14.29M
P/E Ratio-8.33
PEG Ratio0.21
Price/Sales Ratio6.21
Price/Book Ratio1.31
Enterprise/Revenue5.99
Enterprise/EBITDA-14.95

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.5
Operating Margin-0.59
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.16

Income Statement

Revenue3.88M
Revenue/Share0.01
Gross Profit1.14M
EBITDA-1.56M
Net Income-1.96M
Diluted EPS-0

Balance Sheet

Total Cash1.85M
Total Cash/Share0
Total Debt571,862
Total Debt/Equity0.05
Current Ratio1.95
Book Value Per Share0.02

Price History

52-Week Change30.43
52-Week High5
52-Week Low1.9
Moving Average 50 Days2.45
Moving Average 200 Days2.97

Statistics

Average Volume740,187
Shares Outstanding803.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD